Health Condition 1: M109- Gout, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: SUBJECTS FULFILLING CRITERIAS OF AMERICAN COLLEGE OF RHEUMATOLOGY 1977 AND SUBJECTS WITH INCREASED LEVEL OF SERUM URIC ACID OF 7mg/dl to 10mg/dl IN MALE AND 6mg/dl to 10mg/dl IN FEMALE
Exclusion criteria
Exclusion criteria: 1. SUBJECTS DIAGNOSED WITH OTHER INFLAMMATORY AND DEGENERATIVE JOINT DISEASE 2. SUBJECTS WITH HISTORY OF TRAUMA, FRACTURE JOINT, SURGICAL OR DIAGNOSTIC INTERVENTION WITH REFERENCE TO THE AFFECTED JOINT(S) IN PAST 1 YEAR. 3. PREGNANT AND LACTATING WOMEN 4. SUBJECTS WITH ANY UNCONTROLLED SYSTEMIC ILLNESS INCLUDING DIABETES MELLITUS, HYPERTENSION. 5. SUBJECTS WITH VATARAKTA WITH SPECIAL REFERENCE TO GOUTY ARTHRITIS PRESENTING WITH COMPLICATION INCLUDING JOINT DEFORMITIES. 6. ANY OTHER CONDITION INTERFERING THE COURSE OF TREATMENT.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| REDUCTION IN THE LEVELS OF SERUM URIC ACIDTimepoint: 30TH DAY, 45TH DAY | — |
Secondary
| Measure | Time frame |
|---|---|
| REDUCTION IN THE CLASSICAL SIGNS AND SYMPTOMS OF VATARAKTATimepoint: REDUCTION IN THE SIGNS AND SYMPTOMS OF VATARAKTA ON 15th day, 30th DAY and 45th day | — |
Countries
India
Contacts
SRI SRI COLLEGE OF AYURVEDIC SCIENCE AND RESEARCH